Application of neurochemical markers for assessing health effects after developmental methylmercury and PCB coexposure

E. Roda, L. Manzo, T. Coccini

Research output: Contribution to journalArticlepeer-review

Abstract

Cholinergic muscarinic receptors (MRs) and monoamine oxidase activity (MAO-B), expressed both in brain and blood cells, were investigated in animals and exposed subjects to assess (i) MeHg (0.5-1mg/kg/day GD7-PD7) and/or PCB153 (20mg/kg/day GD10-GD16) effects on cerebellar MAO-B and MRs, and lymphocyte MRs, in dams and offspring 21 days postpartum; (ii) MAO-B in platelets and MRs in lymphocytes of a Faroese 7-year-old children cohort, prenatally exposed to MeHg/PCBs. Animal Data. MAO-B was altered in male cerebellum by MeHg, PCB153, and their combination (35%, 45%, and 25% decrease, resp.). Cerebellar MRs were enhanced by MeHg alone in dams (87%) and male pups (27%). PCB153 alone and in mixture did not modify cerebellar MRs. Similarly to brain, lymphocyte MRs were enhanced in both dams and offspring by MeHg alone. All changes were caused by 1MeHg mg/kg/day, the lower dose was ineffective. Human Data. Both biomarkers showed homogeneous distributions within the cohort (MRs, range 0.1-36.78fmol/million cells; MAO-B, 0.95-14.95nmol/mg protein/h). No correlation was found between the two biomarkers and neurotoxicant concentrations in blood (pre- and postnatally).

Original languageEnglish
Article number216032
JournalJournal of Toxicology
Volume2012
DOIs
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'Application of neurochemical markers for assessing health effects after developmental methylmercury and PCB coexposure'. Together they form a unique fingerprint.

Cite this